Anton Pottegård

Medicin og biovidenskab

1. Denmark 100%
2. Drug Utilization 69%
3. Prescriptions 58%
4. Cohort Studies 57%
5. Pharmaceutical Preparations 53%
6. Case-Control Studies 47%
7. Registries 42%
8. Confidence Intervals 41%
9. Odds Ratio 37%
10. Population 31%
11. Anticoagulants 27%
12. Hydroxymethylglutaryl-CoA Reductase Inhibitors 26%
13. Warfarin 25%
14. Vitamin K 23%
15. Deprescriptions 23%
16. Skin Neoplasms 22%
17. Prescription Drugs 22%
18. Hydrochlorothiazide 22%
19. Pharmacoepidemiology 21%
20. Databases 20%
21. Scandinavian and Nordic Countries 19%
22. Delivery of Health Care 17%
23. Therapeutics 17%
24. Adrenal Cortex Hormones 17%
25. Atrial Fibrillation 17%
26. Proton Pump Inhibitors 16%
27. Mortality 16%
28. Systematic Reviews 15%
29. Melanoma 15%
30. Propensity Score 15%
31. International Normalized Ratio 14%
32. Neoplasms 14%
33. phthalic acid 14%
34. Child 14%
35. SARS Virus 13%
36. Severe Acute Respiratory Syndrome 13%
37. Anti-Inflammatory Agents 13%
38. Incidence 12%
39. Coronavirus 12%
40. Health 12%
41. Sweden 12%
42. Hemorrhage 12%
43. Aspirin 12%
44. Norway 12%
45. Antidepressive Agents 11%
46. Dicloxacillin 11%
47. Comorbidity 11%
48. Stroke 11%
49. Pharmacists 10%
50. Life Expectancy 10%